tiprankstipranks
Strata Skin Sciences Reports Mixed Q2 Financials and Device Installations
Company Announcements

Strata Skin Sciences Reports Mixed Q2 Financials and Device Installations

Don't Miss our Black Friday Offers:

Strata Skin Sciences (SSKN) has provided an update.

STRATA Skin Sciences, Inc. revealed preliminary financial figures for Q2 2024, with revenues expected between $8.0 million to $8.4 million, despite a slight decrease in its XTRAC® device installations. In contrast, installations of TheraClear®X devices showed growth, and the company ended the quarter with $6.8 million in cash and equivalents. The report also contains forward-looking statements, advising investors of potential risks and urging them to review further disclosures for a more informed perspective.

For an in-depth examination of SSKN stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyStrata Skin Sciences files $25M mixed securities shelf
TipRanks Auto-Generated NewsdeskSTRATA Skin Sciences Achieves First Profit Since 2018
TipRanks Auto-Generated NewsdeskStrata Skin Sciences Achieves Turnaround with Revenue Growth
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App